Lyka Labs Ltd.
BSE: 500259 | Sector: Health care |
NSE: LYKALABS | ISIN Code: INE933A01014 |
BSE 00:00 | 16 May | 134.15 |
6.35 (4.97%) |
OPEN
134.15 |
HIGH
134.15 |
LOW
131.00 |
NSE 00:00 | 16 May | 134.55 |
(%) |
OPEN
133.90 |
HIGH
134.55 |
LOW
131.25 |
OPEN | 134.15 |
PREVIOUS CLOSE | 127.80 |
VOLUME | 2411 |
52-Week high | 267.20 |
52-Week low | 47.05 |
P/E | 6.57 |
Mkt Cap.(Rs cr) | 385 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Lyka Labs Ltd. (LYKALABS) - Mutual Fund Holding
Stocks attracting Fund Managers | |||
SCHEME | Amount Invested (Rs cr) | No of shares | Net Asset (%) |
Quant Small Cap Fund - (G) | 9.76 | 616064 | 0.54 |
Quant Small Cap Fund - Direct (IDCW) | 9.76 | 616064 | 0.54 |
Quant Small Cap Fund - Direct (G) | 9.76 | 616064 | 0.54 |
Quant Small Cap Fund - (IDCW) | 9.76 | 616064 | 0.54 |
Quant Value Fund - Direct (IDCW) | 3.46 | 218280 | 0.75 |
Quant Value Fund - Direct (G) | 3.46 | 218280 | 0.75 |
Quant Value Fund (IDCW) | 3.46 | 218280 | 0.75 |
Quant Value Fund (G) | 3.46 | 218280 | 0.75 |
Quant Multi Asset Fund - Direct (IDCW) | 1.44 | 91059 | 0.49 |
Quant Multi Asset Fund (G) | 1.44 | 91059 | 0.49 |
Quant Multi Asset Fund - Direct (G) | 1.44 | 91059 | 0.49 |
Quant Multi Asset Fund (IDCW) | 1.44 | 91059 | 0.49 |
Quant Active Fund (G) | 1.37 | 86500 | 0.06 |
Quant Active Fund - Direct (G) | 1.37 | 86500 | 0.06 |
Quant Active Fund (IDCW) | 1.37 | 86500 | 0.06 |
Quant Active Fund - Direct (IDCW) | 1.37 | 86500 | 0.06 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices